Literature DB >> 21371593

Practical aspects of NMR-based fragment screening.

Christopher A Lepre1.   

Abstract

NMR spectroscopy is a popular and highly versatile screening method for fragment-based drug discovery. NMR methods are capable of robustly detecting the binding of fragments to macromolecular targets over an extraordinarily broad affinity range (from covalent to millimolar). This chapter provides a stepwise process for creating an NMR-based fragment screening program. The construction of fragment libraries is described, including compound selection, plating of stocks, and preparation of mixtures. Guidance is given for designing fragment screens, such as choosing the appropriate NMR screening format and method, and optimizing the sample conditions and experimental parameters. The identification and validation of screening hits is described, and a number of potential pitfalls are discussed. Rather than detailing one specific screening protocol, this chapter outlines the available options and provides information to enable users to design their own customized fragment screening programs.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21371593     DOI: 10.1016/B978-0-12-381274-2.00009-1

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  14 in total

Review 1.  Fragment-based inhibitor discovery against β-lactamase.

Authors:  Derek A Nichols; Adam R Renslo; Yu Chen
Journal:  Future Med Chem       Date:  2014-03       Impact factor: 3.808

Review 2.  Oncogenic protein interfaces: small molecules, big challenges.

Authors:  Tracy L Nero; Craig J Morton; Jessica K Holien; Jerome Wielens; Michael W Parker
Journal:  Nat Rev Cancer       Date:  2014-03-13       Impact factor: 60.716

3.  Protein-observed (19)F-NMR for fragment screening, affinity quantification and druggability assessment.

Authors:  Clifford T Gee; Keith E Arntson; Andrew K Urick; Neeraj K Mishra; Laura M L Hawk; Andrea J Wisniewski; William C K Pomerantz
Journal:  Nat Protoc       Date:  2016-07-14       Impact factor: 13.491

Review 4.  Twenty years on: the impact of fragments on drug discovery.

Authors:  Daniel A Erlanson; Stephen W Fesik; Roderick E Hubbard; Wolfgang Jahnke; Harren Jhoti
Journal:  Nat Rev Drug Discov       Date:  2016-07-15       Impact factor: 84.694

5.  Rapid Quantification of Protein-Ligand Binding via 19F NMR Lineshape Analysis.

Authors:  Samantha S Stadmiller; Jhoan S Aguilar; Christopher A Waudby; Gary J Pielak
Journal:  Biophys J       Date:  2020-04-15       Impact factor: 4.033

6.  Fragment screening and druggability assessment for the CBP/p300 KIX domain through protein-observed 19F NMR spectroscopy.

Authors:  Clifford T Gee; Edward J Koleski; William C K Pomerantz
Journal:  Angew Chem Int Ed Engl       Date:  2015-02-04       Impact factor: 15.336

7.  Design of a fragment library that maximally represents available chemical space.

Authors:  M N Schulz; J Landström; K Bright; R E Hubbard
Journal:  J Comput Aided Mol Des       Date:  2011-07-27       Impact factor: 3.686

8.  Statistical removal of background signals from high-throughput (1)H NMR line-broadening ligand-affinity screens.

Authors:  Bradley Worley; Nicholas J Sisco; Robert Powers
Journal:  J Biomol NMR       Date:  2015-07-09       Impact factor: 2.835

Review 9.  Fragment-based drug discovery using NMR spectroscopy.

Authors:  Mary J Harner; Andreas O Frank; Stephen W Fesik
Journal:  J Biomol NMR       Date:  2013-05-18       Impact factor: 2.835

10.  NMR waterLOGSY as An Assay in Drug Development Programmes for Detecting Protein-Ligand Interactions-NMR waterLOGSY.

Authors:  Carole J R Bataille; Terence H Rabbitts; Timothy D W Claridge
Journal:  Bio Protoc       Date:  2020-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.